IGF1 and acromegaly: Furthermore, while cabergoline monotherapy, used off-label in acromegaly, is recommended only for patients with mild elevations of IGF-I levels and symptoms [12], participating centers very rarely reported cabergoline monotherapy as a first option, prescribing it in < 10% of medically treated patients.